TADALAFIL
NDC 70518-3931, tadalafil, tablet, from REMEDYREPACK INC..
- Product NDC
- 70518-3931
- Status
- Listed
- Labeler
- REMEDYREPACK INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210608
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70518-3931 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TADALAFIL20 mg/1
Pharmacologic classes
Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70518-3931-0 | 70518393100 | 12 TABLET in 1 BOTTLE, PLASTIC (70518-3931-0) |
| 70518-3931-1 | 70518393101 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-3931-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/cec49f6c-71f1-4de7-b515-1612ae16e5db
Use it
Look up 70518-3931 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70518-3931 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70518-3931. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.